Evidence map›Paper›PMID 39433833›Full record

ArticleScientific reports2024

iDLB-Pred: identification of disordered lipid binding residues in protein sequences using convolutional neural network.

Sharaf J Malebary, Nashwan Alromema

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sharaf J MalebaryDepartment of Information Technology, Faculty of Computing and Information Technology-Rabigh, King Abdulaziz University, P.O. Box 344, 21911, Rabigh, Saudi Arabia. smalebary@kau.edu.sa.
Nashwan AlromemaDepartment of Computer Science, Faculty of Computing and Information Technology-Rabigh, King Abdulaziz University, P.O. Box 344, 21911, Rabigh, Saudi Arabia.

Funding

Ministry of Education and King Abdulaziz University, DSR, Jeddah, Saudi Arabia. IFPIP: 801-830-1443
6 · The paper itself

Abstract

Proteins, nucleic acids, and lipids all interact with intrinsically disordered protein areas. Lipid-binding regions are involved in a variety of biological processes as well as a number of human illnesses. The expanding body of experimental evidence for these interactions and the dearth of techniques to anticipate them from the protein sequence serve as driving forces. Although large-scale laboratory techniques are considered to be essential for equipment for studying binding residues, they are time consuming and costly, making it challenging for researchers to predict lipid binding residues. As a result, computational techniques are being looked at as a different strategy to overcome this difficulty. To predict disordered lipid-binding residues (DLBRs), we proposed iDLB-Pred predictor utilizing benchmark dataset to compute feature through extraction techniques to identify relevant patterns and information. Various classification techniques, including deep learning methods such as Convolutional Neural Networks (CNNs), Deep Neural Networks (DNNs), Multilayer Perceptrons (MLPs), Recurrent Neural Networks (RNNs), Long Short-Term Memory (LSTM) networks, and Gated Recurrent Units (GRUs), were employed for model training. The proposed model, iDLB-Pred, was rigorously validated using metrics such as accuracy, sensitivity, specificity, and Matthew's correlation coefficient. The results demonstrate the predictor's exceptional performance, achieving accuracy rates of 81% on an independent dataset and 86% in 10-fold cross-validation.

Indexed as

LipidsNeural Networks, ComputerAmino Acid SequenceBinding SitesComputational BiologyDatabases, ProteinDeep LearningHumansIntrinsically Disordered ProteinsProtein BindingIntrinsically Disordered ProteinsLipidsConvolutional neural networkDisordered lipid binding residuesFeature descriptionIntrinsic disordered regionsTen-fold cross validation

Identifiers

PMID39433833
PMCPMC11494137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.